FZD10 (OTSA-101-DTPA-90Y Biosimilar) Recombinant Monoclonal Antibody

Code CSB-RA891782MB1HU
Size US$9799
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
Alternative Names
OTSA-101-DTPA-90Y research-grade biosimilar ;FZD10 antibody; Frizzled-10 antibody; Fz-10 antibody; hFz10 antibody; FzE7 antibody; CD antigen CD350 antibody
Species Reactivity
Human
Immunogen
Recombinant Human FZD10 protein
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
0.01M PBS,pH7.4
Form
Liquid
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Lead Time
3-4 weeks
Description

This recombinant monoclonal antibody is a research-grade biosimilar of OTSA-101-DTPA-⁹⁰Y, targeting FZD10 (Frizzled-10)—a 7-transmembrane Wnt signaling receptor in the frizzled family. FZD10 has been reported to be highly overexpressed in synovial sarcoma (SS) while showing little to no expression in most normal adult tissues (with limited exceptions such as placenta), making it an attractive tumor-associated surface target for antigen profiling and target-engagement studies.

OTSA-101-DTPA-⁹⁰Y is a radioimmunoconjugate in which the anti-FZD10 monoclonal antibody OTSA-101 is chelator-conjugated (e.g., DTPA) and labeled with yttrium-90 to deliver β-radiation selectively to FZD10-expressing lesions; related clinical studies have also used ¹¹¹In-labeled OTSA-101 for biodistribution/uptake assessment. This biosimilar provides the antibody component alone, enabling researchers to investigate FZD10 biology, cell-surface binding, and target-mediated internalization/trafficking independent of radiotoxicity, and to support assay development or custom conjugation workflows (e.g., chelator coupling for imaging/therapy research).

Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Receptor for Wnt proteins. Functions in the canonical Wnt/beta-catenin signaling pathway. The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable).
Gene References into Functions
  1. there was a strong inverse correlation between nuclear immunostaining scores for beta-catenin expression and expression patterns of FZD10 PMID: 19134005
  2. FZD10 transactivation causes the activation of the Dvl-Rac1-JNK pathway and is associated with the development/progression of synovial sarcomas PMID: 19137009
Subcellular Location
Cell membrane; Multi-pass membrane protein.
Protein Families
G-protein coupled receptor Fz/Smo family
Tissue Specificity
Highest levels in the placenta and fetal kidney, followed by fetal lung and brain. In adult brain, abundantly expressed in the cerebellum, followed by cerebral cortex, medulla and spinal cord; very low levels in total brain, frontal lobe, temporal lobe an
Database Links

HGNC: 4039

OMIM: 606147

KEGG: hsa:11211

STRING: 9606.ENSP00000229030

UniGene: Hs.31664

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*